ECMC Combinations Alliance
The ECMC Combinations Alliance is a joint initiative between Cancer Research UK’s Drug Development Office (DDO) and the ECMC Network. It aims to support industry collaborations to deliver investigator led combination studies of novel agents.
Developed to increase the number of rationally designed combination therapies being tested within the UK, it enables academia to work with industry in a consistent and efficient framework.
The Alliance will govern the process through a joint steering committee and can act as an independent broker between cross company collaborations.
How we add value, success criteria & more
The steps from study concept to delivery
How academics can get involved
Realise further potential of your pipeline
ECMC Combinations Alliance governance
Library of study SOPs, templates and forms
Increase text
Decrease text
Print this page